Bearish flow noted in Bristol Myers (BMY) Squibb with 9,747 puts trading, or 1.5x expected. Most active are 8/1 weekly 46 puts and Aug-25 47 calls, with total volume in those strikes near 6,100 contracts. The Put/Call Ratio is 2.23, while ATM IV is up over 1 point on the day. Earnings are expected on July 31st.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol-Myers Squibb’s Promising Study on Advanced Solid Tumors: A Potential Game-Changer
- Bristol-Myers Squibb’s New Lung Cancer Study: Market Implications
- Bristol-Myers Squibb’s Promising Lupus Study: A Potential Game-Changer
- Bristol-Myers Squibb’s KarXT Study: A Potential Game-Changer in Schizophrenia Treatment
- Bristol-Myers Squibb’s Strategic Immunology Venture with Bain Capital Justifies Buy Rating